Sponsor:University of California, San FranciscoBrief Summary: Photobiomodulation (PBM) describes the use of near-infrared light (which is not visible to the…
Sponsor:Stemedica Cell Technologies, Inc.Brief Summary: STUDY OBJECTIVES Primary: To assess the safety and tolerability of ischemia-tolerant allogeneic human mesenchymal stem…
Sponsor:Avanir PharmaceuticalsBrief Summary: This study will be conducted to evaluate the efficacy, safety, and tolerability of AVP-786 (deudextromethorphan hydrobromide [d6-DM]/quinidine…
Sponsor:New York State Psychiatric InstituteBrief Summary: This protocol focuses on novel measures of cognition and everyday function that have robust…
Sponsor:AriBio Co., Ltd.Brief Summary: A double-blinded, randomized, placebo-controlled study will be performed to evaluate the efficacy and safety of treating…
Sponsor:Avanir PharmaceuticalsBrief Summary: This study will be conducted to evaluate the efficacy, safety, and tolerability of AVP-786 compared to placebo,…
Sponsor:University of Southern CaliforniaBrief Summary: The purpose of this study is to examine the effects of modifiable lifestyle factors including…
Sponsor: Genentech, Inc. Information provided by (Responsible Party): Genentech, Inc. Brief Summary: This Phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group…
Sponsor: Cortexyme Inc. Information provided by (Responsible Party): Cortexyme Inc. Brief Summary: This is a randomized, double-blind, placebo-controlled study that…
Sponsor: Eisai Inc. Collaborator: Biogen Information provided by (Responsible Party): Eisai Inc. Brief Summary: This study will be conducted to…
